Kezar Life Sciences, Inc.
KZRDelisted May 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645666
Kezar Life Sciences, Inc. was delisted on May 11, 2026; its insiders filed their last Form 4 on May 11, 2026; 43 institutions reported holding it in 13F filings for Q1 2026, worth $32.8M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 43
- Q1 2026, +3 vs. previous quarter
- 13F value
- $32.8M
- Reported value at the end of Q1 2026
- Superinvestors holding
- 0
- At the end of Q1 2026
Superinvestors holding KZR, Q1 2026
No superinvestor reported holding KZR at the end of Q1 2026.
Latest insider trades
Open-market purchases and sales by Kezar Life Sciences, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 3, 2025 (view filing) | Jul 2 | 1 day | Chiang Pichi LuoSVP, Corporate Controller | SSale | −264 | $4.28 | −$1.13K | −8.9%2.71K after | |
| Jul 3, 2025 (view filing) | Jul 2 | 1 day | Schiller Mark C.Chief Operating Officer | SSale | −561 | $4.28 | −$2.40K | −17.0%2.74K after | |
| Jul 26, 2024 (view filing) | Jul 2 | 24 daysLate | Schiller Mark C.Chief Legal Officer | SSale | −6.69K | $0.58 | −$3.88K | −16.8%33.0K after | |
| Feb 7, 2023 (view filing) | Feb 3-6 | 4 days | Morningside Venture Investments Ltd10% Owner | SSale | −65.0K | $6.98 | −$453.9K | −1.2%5.45M after | 2 lots |
| Feb 3, 2023 (view filing) | Feb 1-2 | 2 days | Morningside Venture Investments Ltd10% Owner | SSale | −90.0K | $7.08 | −$637.5K | −1.6%5.51M after | 2 lots |
| Feb 1, 2023 (view filing) | Jan 30-31 | 2 days | Morningside Venture Investments Ltd10% Owner | SSale | −60.0K | $7.00 | −$419.7K | −1.1%5.60M after | 2 lots |
| Jan 27, 2023 (view filing) | Jan 25 | 2 days | Morningside Venture Investments Ltd10% Owner | SSale | −50.0K | $6.85 | −$342.5K | −0.9%5.66M after | |
| Jan 25, 2023 (view filing) | Jan 23-24 | 2 days | Morningside Venture Investments Ltd10% Owner | SSale | −160.0K | $6.90 | −$1.10M | −2.7%5.71M after | 2 lots |
| Jan 19, 2023 (view filing) | Jan 17 | 2 days | Morningside Venture Investments Ltd10% Owner | SSale | −6.11K | $6.79 | −$41.5K | −0.1%5.87M after | |
| Jan 17, 2023 (view filing) | Jan 12-13 | 5 days | Morningside Venture Investments Ltd10% Owner | SSale | −6.97K | $6.88 | −$47.9K | −0.1%5.88M after | 2 lots |
Top 10 13F holders, Q1 2026
The largest institutional positions in Kezar Life Sciences, Inc. at the end of Q1 2026; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BML Capital Management, LLC | 720,787 | $5.35M | 3.44% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 716,759 | $5.32M | 0.14% | 00.0% | Unchanged |
| Tang Capital Management LLC | 664,314 | $4.93M | 0.25% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 290,529 | $2.16M | 0.00% | +290,529 | New |
| Rangeley Capital, LLC | 243,073 | $1.80M | 1.95% | +157,147+182.9% | Added |
| Affinity Asset Advisors, LLC | 229,076 | $1.70M | 0.10% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 188,426 | $1.40M | 0.00% | +57,141+43.5% | Added |
| Acadian Asset Management LLC | 151,630 | $1.12M | 0.00% | +26,259+20.9% | Added |
| Millennium Management LLC | 142,050 | $1.05M | 0.00% | +142,050 | New |
| Peapod Lane Capital LLC | 126,692 | $924.5K | 0.76% | −70.0% | Reduced |
Holders of 5% or more of KZR
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Kezar Life Sciences, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Equal Talent Investments Ltd | 13D/A | 8.66%616.5K shares | – | Mar 3, 20251 filing | Mar 3, 2025 | SEC |
| Morningside Venture Investments Ltd | 13D/A | 8.45%616.5K shares | – | Feb 16, 20213 filings | Jan 16, 2025 | SEC |
| Avidity Partners Management LP | 13G/A | 6.90%502.6K shares | – | Jan 3, 20224 filings | Feb 14, 2025 | SEC |